Israel’s Immunai first to map whole immune system, scores $20m. investment
Immunai says it has mapped out millions of immune cells and their functions that could help detect, diagnose and treat cancer and many other diseases.
Immunai co-founders (from left) Luis Voloch and Noam Solomon